deltatrials
Completed OBSERVATIONAL NCT05161130

Predicting Outcomes After Lumbar Fusion for Degenerative Disease (FUSE-ML)

Development and External Validation of an International, Multicenter Machine Learning Algorithm for Prediction of Outcome After Lumbar Spinal Fusion for Degenerative Disease: The FUSE-ML Study

Sponsor: Bergman Clinics

Updated 5 times since 2022 Last updated: Dec 17, 2021 Started: Jan 1, 2021 Primary completion: Nov 1, 2021 Completion: Nov 1, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05161130, this observational or N/A phase trial focuses on Disk Herniated Lumbar and Low Back Pain and remains completed. Sponsored by Bergman Clinics, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshotCompleted~Feb 2022 – ~Jul 2024 · 29 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshotCompleted~Apr 2025 – present · 15 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Apr 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Apr 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Feb 2022 — Jul 2024 [monthly]

    Completed

  5. Jan 2022 — Feb 2022 [monthly]

    Completed

    First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bergman Clinics
  • University of Zurich
Data source: Bergman Clinics

For direct contact, visit the study record on ClinicalTrials.gov .